US
Govt hopes to give the first dose of Oxford or the Pfizer vaccine to 2 million people over the next two weeks
Some questions have been raised about the Oxford/AstraZeneca data and the robustness of that result
AstraZeneca is facing tricky questions about its success rate that could hinder chances of getting speedy approval
Vaccine in the right dosage can be up to 90% effective
Findings should offer some reassurance for more than 51 million people who have been infected, researchers say
Manufacturers say vaccine was undergoing larger, more comprehensive phase 3 trials to confirm results
The young activist didn’t get to savour her final months at the university
Though today’s results were widely welcomed, larger trials still need to take place to determine vaccine’s efficacy
The UN Goodwill ambassador congratulated Pakistan's Nobel Peace Prize laureate on her graduation
The youngest Nobel Prize laureate recently complete her degree in Philosophy, Politics and Economics